What is the normal range of B-type natriuretic peptide in pregnancy, and what B-type natriuretic peptide levels are concerning for peripartum cardiomyopathy?

BNP Values in Normal Pregnancy and Peripartum Cardiomyopathy

In normal pregnancy, BNP should remain ≤50 pg/mL across all trimesters, while NT-proBNP should be ≤200 pg/mL in the first and second trimesters and ≤150 pg/mL in the third trimester; any BNP >100 pg/mL should raise significant concern for peripartum cardiomyopathy and warrants immediate echocardiographic evaluation. 1, 2

Normal BNP Values in Pregnancy

Healthy pregnant women maintain consistently low natriuretic peptide levels throughout gestation:

• BNP remains stable at median values <20 pg/mL throughout all trimesters, with an upper reference limit of 50 pg/mL showing no significant trimester-related variation 1, 3
• NT-proBNP has trimester-specific upper limits: 200 pg/mL in the first and second trimesters, decreasing to 150 pg/mL in the third trimester 1
• The median NT-proBNP in healthy postpartum mothers is approximately 339.5 fmol/mL (roughly 40 pg/mL when converted) 4

Important physiologic consideration: Despite the 40% increase in plasma volume and 30-50% increase in cardiac output during normal pregnancy, natriuretic peptides initially rise slightly in early pregnancy but then fall by the third trimester due to progressive hemodilution 1. This dynamic interplay between cardiac strain and hemodilution explains why the upper reference limit actually decreases in the third trimester for NT-proBNP 1.

Body mass index significantly affects interpretation: Overweight women have significantly lower NT-proBNP levels in the third trimester (P = 0.0001), which supports using BMI-stratified reference intervals when available 1.

BNP Values Concerning for Peripartum Cardiomyopathy

The critical threshold for concern is BNP >100 pg/mL, which demonstrates exceptional diagnostic performance:

• BNP >100 pg/mL has 98% sensitivity, 92% specificity, 92% positive predictive value, and 97% negative predictive value for cardiac complications in pregnancy 5
• All women who experienced cardiac events during pregnancy had BNP >100 pg/mL, while no woman with BNP ≤100 pg/mL experienced events, yielding a 100% negative predictive value 6
• BNP ≥111 pg/mL (95% CI 78-291) is the optimal cutoff for diagnosing heart failure in pregnant/postpartum women, with 95% sensitivity and 62% specificity 2

In confirmed PPCM cases, natriuretic peptides are markedly elevated:

• Mean NT-proBNP in PPCM patients is 1727.2 fmol/mL (approximately 205 pg/mL) compared to 339.5 fmol/mL in healthy postpartum mothers (P < 0.0001) 4
• Median BNP in women with heart failure during pregnancy is 326 pg/mL (interquartile range 200.5-390.5) versus 75.5 pg/mL in those without heart failure (P < 0.01) 2
• Women with heart disease during pregnancy have median peak BNP of 79 pg/mL (interquartile range 51-152) compared to 35 pg/mL (21-43) in healthy controls (P < 0.001) 6

Clinical Application Algorithm

When evaluating suspected PPCM, use this stepwise approach:

1. BNP ≤50 pg/mL or NT-proBNP ≤150-200 pg/mL: PPCM is highly unlikely; consider alternative diagnoses for symptoms 1, 2

2. BNP 50-100 pg/mL: Intermediate risk zone requiring clinical correlation with symptoms, physical examination findings (displaced apical impulse, third heart sound, mitral regurgitation), and ECG abnormalities 4, 2

3. BNP >100 pg/mL: High probability of cardiac dysfunction; proceed immediately to echocardiography to assess left ventricular ejection fraction and exclude LV thrombus (particularly if LVEF <35%) 4, 2, 6

4. BNP >200 pg/mL: Very high concern for significant cardiac dysfunction requiring urgent cardiology consultation and consideration of advanced heart failure therapies 2

Critical Caveats and Pitfalls

PPCM is a diagnosis of exclusion, so elevated BNP must be interpreted in context of other cardiac and non-cardiac causes 4. The differential includes pre-existing dilated cardiomyopathy unmasked by pregnancy, valvular heart disease, hypertensive heart disease, pregnancy-associated myocardial infarction, and pulmonary embolism 4.

Pre-eclampsia confounds interpretation: Severe pre-eclampsia causes elevated BNP (median 101 pg/mL) compared to normal pregnancy (17.8 pg/mL) or mild pre-eclampsia (21.1 pg/mL), with P < 0.001 3. A BNP <40.6 pg/mL has 92% negative predictive value for excluding pre-eclampsia 3. Studies that included more pre-eclampsia patients showed earlier presentation of PPCM (last month of pregnancy), while those excluding pre-eclampsia showed the typical postpartum peak 2-62 days after delivery 4.

Timing matters: First trimester NT-proBNP may be numerically higher (116 pg/mL) in women who subsequently develop PPCM compared to controls (37.6-56.1 pg/mL), suggesting early subclinical myocardial dysfunction may precede clinical disease 7. However, this requires validation before clinical application.

Serial measurements are superior to single values for monitoring disease progression and treatment response, with repeat echocardiography recommended at discharge, 6 weeks, 6 months, and annually 4.